Aaron R Folsom1, Saonli Basu2, Ching-Ping Hong3, Susan R Heckbert4, Pamela L Lutsey3, Wayne D Rosamond5, Mary Cushman6. 1. Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis. Electronic address: folso001@umn.edu. 2. Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis. 3. Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis. 4. Department of Epidemiology, Cardiovascular Health Research Unit, University of Washington, Seattle. 5. Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill. 6. Department of Medicine, University of Vermont, Colchester Research Facility, Colchester; Department of Pathology, University of Vermont, Main Campus, Burlington.
Abstract
INTRODUCTION: Venous thromboembolism incidence rates are 30%-100% higher in US blacks than whites. We examined the degree to which differences in the frequencies of socioeconomic, lifestyle, medical risk factors, and genetic variants explain the excess venous thromboembolism risk in blacks and whether some risk factors are more strongly associated with venous thromboembolism in blacks compared with whites. METHODS: We measured venous thromboembolism risk factors in black and white participants of the Atherosclerosis Risk in Communities study in 1987-1989 and followed them prospectively through 2015 for venous thromboembolism incidence. RESULTS: Over a mean of 22 years, we identified 332 venous thromboembolisms in blacks and 578 in whites, yielding 65% higher crude incidence rates per 1000 person-years in blacks. The age and sex-adjusted hazard ratio (95% confidence interval) of venous thromboembolism for blacks compared with whites was 2.04 (1.76, 2.37) for follow-up >10 years and was attenuated to 1.14 (0.89, 1.46) when adjusted for baseline confounders or mediators of the race association, which tended to be more common in blacks. For example, adjustment for just baseline weight, family income, and concentration of plasma factor VIII reduced the regression coefficient for race by 75%. There were no significant (P <0.05) 2-way multiplicative interactions of race with any risk factor, except with a 5-single nucleotide polymorphism (5-SNP) genetic risk score (a weaker venous thromboembolism risk factor in blacks) and with hospitalization for heart failure (a stronger venous thromboembolism risk factor in blacks). CONCLUSION: The higher incidence rate of venous thromboembolism in blacks than whites was mostly explained by blacks having higher frequencies of venous thromboembolism risk factors.
INTRODUCTION:Venous thromboembolism incidence rates are 30%-100% higher in US blacks than whites. We examined the degree to which differences in the frequencies of socioeconomic, lifestyle, medical risk factors, and genetic variants explain the excess venous thromboembolism risk in blacks and whether some risk factors are more strongly associated with venous thromboembolism in blacks compared with whites. METHODS: We measured venous thromboembolism risk factors in black and white participants of the Atherosclerosis Risk in Communities study in 1987-1989 and followed them prospectively through 2015 for venous thromboembolism incidence. RESULTS: Over a mean of 22 years, we identified 332 venous thromboembolisms in blacks and 578 in whites, yielding 65% higher crude incidence rates per 1000 person-years in blacks. The age and sex-adjusted hazard ratio (95% confidence interval) of venous thromboembolism for blacks compared with whites was 2.04 (1.76, 2.37) for follow-up >10 years and was attenuated to 1.14 (0.89, 1.46) when adjusted for baseline confounders or mediators of the race association, which tended to be more common in blacks. For example, adjustment for just baseline weight, family income, and concentration of plasma factor VIII reduced the regression coefficient for race by 75%. There were no significant (P <0.05) 2-way multiplicative interactions of race with any risk factor, except with a 5-single nucleotide polymorphism (5-SNP) genetic risk score (a weaker venous thromboembolism risk factor in blacks) and with hospitalization for heart failure (a stronger venous thromboembolism risk factor in blacks). CONCLUSION: The higher incidence rate of venous thromboembolism in blacks than whites was mostly explained by blacks having higher frequencies of venous thromboembolism risk factors.
Authors: Wayne D Rosamond; Patricia P Chang; Chris Baggett; Anna Johnson; Alain G Bertoni; Eyal Shahar; Anita Deswal; Gerardo Heiss; Lloyd E Chambless Journal: Circ Heart Fail Date: 2012-01-23 Impact factor: 8.790
Authors: Aaron R Folsom; Amil M Shah; Pamela L Lutsey; Nicholas S Roetker; Alvaro Alonso; Christy L Avery; Michael D Miedema; Suma Konety; Patricia P Chang; Scott D Solomon Journal: Am J Med Date: 2015-04-20 Impact factor: 4.965
Authors: Neil A Zakai; Leslie A McClure; Suzanne E Judd; Monika M Safford; Aaron R Folsom; Pamela L Lutsey; Mary Cushman Journal: Circulation Date: 2014-02-07 Impact factor: 29.690
Authors: John A Heit; Michele G Beckman; Paula L Bockenstedt; Althea M Grant; Nigel S Key; Roshni Kulkarni; Marilyn J Manco-Johnson; Stephan Moll; Thomas L Ortel; Claire S Philipp Journal: Am J Hematol Date: 2010-07 Impact factor: 10.047
Authors: Corinne E Joshu; John R Barber; Josef Coresh; David J Couper; Thomas H Mosley; Mara Z Vitolins; Kenneth R Butler; Heather H Nelson; Anna E Prizment; Elizabeth Selvin; Janet A Tooze; Kala Visvanathan; Aaron R Folsom; Elizabeth A Platz Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-12-20 Impact factor: 4.254
Authors: Elizabeth J Bell; Pamela L Lutsey; Saonli Basu; Mary Cushman; Susan R Heckbert; Donald M Lloyd-Jones; Aaron R Folsom Journal: Am J Med Date: 2015-11-18 Impact factor: 4.965
Authors: Albert W Tsai; Mary Cushman; Wayne D Rosamond; Susan R Heckbert; Russell P Tracy; Nena Aleksic; Aaron R Folsom Journal: Am J Med Date: 2002-12-01 Impact factor: 4.965
Authors: Kelechi O Weze; Olufunmilayo H Obisesan; Zeina A Dardari; Miguel Cainzos-Achirica; Omar Dzaye; Garth Graham; Michael D Miedema; Joseph Yeboah; Andrew P DeFilippis; Khurram Nasir; Michael J Blaha; Albert D Osei Journal: Am J Prev Med Date: 2022-03-05 Impact factor: 6.604
Authors: Line H Evensen; Aaron R Folsom; James S Pankow; John-Bjarne Hansen; Matthew A Allison; Mary Cushman; Pamela L Lutsey Journal: J Thromb Haemost Date: 2021-05-07 Impact factor: 16.036
Authors: Nipith Charoenngam; Titilayo O Ilori; Michael F Holick; Natasha S Hochberg; Caroline M Apovian Journal: J Gen Intern Med Date: 2021-06-07 Impact factor: 5.128